Journal of Interventional Cardiology

Research Article

Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up

Table 1

Baseline characteristics.


Number of patients	166
Age (years)	56.7 ± 16.1
Female, n (%)	103 (62.0)
BMI (kg/m²)	25.6 ± 4.5
Systolic blood pressure (mmHg)	129.3 ± 17.0
Diastolic blood pressure (mmHg)	79.2 ± 9.3

Risk factors and comorbidities, n (%)
Smoking	23 (13.9)
Diabetes	11 (6.6)
Arterial hypertension	50 (30.1)
Hypercholesterolemia	39 (23.5)
CAD	10 (6.0)
History of AF or AFl	19 (11.4)

Indication for closure, n (%)
RV volume overload	104 (62.7%)
Cryptogenic stroke/TIA	47 (28.3%)
Others	15 (9.0%)

Echocardiography
RVSP (mmHg)	25.4 ± 7.8
Peak TRV (m/sec)	2.5 ± 0.4
Peak TRV (2.9–3.4 m/sec), n (%)	24 (14.5)
Peak TRV (>3.4 m/sec), n (%)	4 (2.4)

Mean follow-up (years)	5.9 ± 2.6

Data are presented as mean ± SD or number (percentage). BMI, body mass index; CAD, coronary artery disease; AF, atrial fibrillation; AFl, atrial flutter; RV, right ventricle; TIA, transient ischemic attack; RVSP, right ventricular systolic pressure.